Overview
Pursuit of innovation is an integral part of our business at Takeda. Our globally active R&D organizations seek to develop drugs to meet real patient needs through innovation in drug discovery. These efforts are underpinned by Takeda’s fundamental policy of concentrating resources into core therapeutic areas, building a competitive drug pipeline and ensuring approvals and increasing R&D productivity.
R&D News
- February 9, 2012
Takeda Announces Establishment of Development Center in China - January 27, 2012
Anti-Prostate Cancer Agent Orteronel(TAK-700) Enters into Phase III Clinical Trials in Japan - January 24, 2012
FDA Approves Subcutaneous Administration of VELCADE® In All Approved Indications - January 18, 2012
New Drug Application Approval for AZILVA® in Japan, a Treatment of Hypertension - January 6, 2012
Establishment of Joint Research Chair by Takeda and Osaka University
Latest Publications of Takeda Research Laboratories
 |
R&D At a Glance
| Main R&D Facilities | The Tsukuba Research Center (Tsukuba, Japan) |
| The Osaka Research Center (Osaka, Japan) | |
| Takeda Ventures, Inc. (Palo Alto, CA, U.S.) | |
| Takeda San Diego, Inc. (San Diego, CA, U.S.) | |
| Takeda San Francisco, Inc. (San Francisco, CA, U.S.) | |
| Takeda Cambridge Limited (Cambridge, U.K.) | |
| Takeda Singapore Pte Limited (Singapore) | |
| Japan Deveropment Center | |
| Takeda Global Research & Development Center, Inc. (Deerfield, IL. U.S.) | |
| Takeda Global Research & Development Centre(Europe), Ltd. (London, U.K.) | |
| Takeda Global Research & Development Center (Asia) Pte. Ltd. | |
| Takeda Bio Development Center Limited (Japan) | |
| Millennium Pharmaceuticals, Inc. (Cambridge, MA, U.S.) | |
| R&D Investment | ¥288.9billion ($3,480million) (FY2010) |
| Royalty Income | ¥41.4billion ($498million) (FY2010) |
| Core Therapeutic Areas |
Metabolic (diabetes, obesity), Oncology Central Nervous System Diseases Immunology / Inflammatory |
| Product Pipeline |
Takeda discloses ethical drugs under development that have reached phase I or higher status |
Note: The US dollar amounts represent translations of Japanese yen, for conveniense only, at the rate of ¥98=US$1 approximate exchange rate at March 31, 2009.